Skip to main content
Skip to main content
CERN logo

Cerner Corporation (CERN) Stock Analysis

$94.92 +$0.00 (+0.00%) |CouncilSplit View · 36 · D
Signals are mixed — the Council read leans Split View (36/100) while the AI fundamental score is 54/100 (grade B); the two lenses disagree, so weigh the breakdown below.
P/E Ratio: 52.4| Vol: 38.20M| 52-wk range: $94.92 – $94.99
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cerner Corporation (CERN) trades at $94.92 with AI Score 54/100 (Grade B). Cerner Corporation, now a subsidiary of Oracle, provides comprehensive healthcare information technology solutions and tech-enabled services globally. Sector: Healthcare.

Price as of Jul 23, 2026 · Last analyzed: Jun 14, 2026
Cerner Corporation, now a subsidiary of Oracle, provides comprehensive healthcare information technology solutions and tech-enabled services globally. Its offerings include electronic health record systems, cloud-based data platforms, and device connectivity solutions for a wide range of healthcare providers.

Analyst Coverage for CERN: CERN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CERN against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Watch the CERN film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 36/100 · D

CERN: 1/3 scored disciplines lean bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Izzy Englander
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Cerner Corporation (CERN) Healthcare & Pipeline Overview

CEOBrent Shafer
Employees25,150
HeadquartersKansas City, US
IPO Year1986

Cerner Corporation, a former independent entity and now an Oracle subsidiary, is a leading global provider of healthcare information technology solutions and tech-enabled services. The company specializes in person-centric computing frameworks, electronic health records, and cloud-based data platforms, serving diverse healthcare organizations internationally.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for CERN?

As of Jun 14, 2026 — figures reflect the data available on that date.

Cerner Corporation, prior to its acquisition by Oracle, represented a significant player in the healthcare information technology sector, characterized by its comprehensive suite of solutions addressing critical needs in patient data management and operational efficiency. The company's Cerner Millennium architecture and HealtheIntent platform were key value drivers, offering integrated EHRs and cloud-based data aggregation capabilities essential for modern healthcare delivery. With a gross margin of 82.6% and a profit margin of 9.6%, Cerner demonstrated strong operational efficiency and profitability in its core business. Its P/E ratio of 52.4 reflected investor confidence in its growth trajectory within the expanding healthcare IT market. The strategic acquisition by Oracle Corporation on June 8, 2022, transformed Cerner into a critical component of Oracle's healthcare strategy, integrating its robust healthcare platforms with Oracle's extensive cloud infrastructure and enterprise solutions. This integration is poised to drive further innovation and market penetration, leveraging Oracle's global reach and technological prowess. The ongoing demand for advanced EHR systems, interoperability, and data analytics in healthcare continues to underpin the inherent value and strategic importance of Cerner's offerings within the broader healthcare ecosystem.

Based on FMP financials and quantitative analysis

CERN Key Highlights

  • Cerner Corporation reported a P/E ratio of 52.4, reflecting investor valuation in the healthcare IT sector prior to its acquisition.
  • The company maintained a strong gross margin of 82.6%, indicating efficient cost management relative to its revenue generation from software and services.
  • Cerner achieved a profit margin of 9.6%, demonstrating its ability to translate revenues into net income within the competitive healthcare technology market.
  • With a Beta of 0.76, Cerner exhibited lower volatility compared to the broader market, suggesting relative stability in its stock performance before becoming a subsidiary.
  • As of June 8, 2022, Cerner Corporation transitioned to operating as a subsidiary of Oracle Corporation, fundamentally altering its corporate structure and market position.

Who Are CERN's Competitors?

CERN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
COR Cencora, Inc. $305.81 +1.74% $60.0B 76
GEHC GE HealthCare Technologies Inc. $61.99 +0.94% $28.2B 63
ONC BeOne Medicines Ltd. $326.77 +2.14% $34.9B 97
HZNP Horizon Therapeutics Public Limited Company $116.30 +0.00% $26.6B 54
ABMD Abiomed, Inc. $381.02 +0.00% $17.2B 60
VEEV Veeva Systems Inc. $179.58 -2.69% $29.2B 84
BTSGU BrightSpring Health Services, Inc. Tangible Equity Unit $230.25 +0.48% $13.8B 90
BTSG BrightSpring Health Services, Inc. $69.84 +0.14% $13.7B 91

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CERN's Key Strengths?

  • Established market leadership in healthcare information technology with a comprehensive suite of EHR and data management solutions.
  • Robust and integrated platforms like Cerner Millennium and HealtheIntent cater to diverse clinical, financial, and administrative needs.
  • Extensive global client base spanning various healthcare organizations, ensuring broad market penetration and recurring revenue streams.
  • Strong tech-enabled services portfolio, including implementation, revenue cycle management, and data analytics, enhancing customer value.
  • Strategic integration with Oracle Corporation provides significant resources, cloud infrastructure, and global market access.

What Are CERN's Weaknesses?

  • Potential for integration challenges and cultural shifts following the acquisition by Oracle Corporation.
  • Reliance on complex legacy systems could pose modernization challenges and require substantial investment.
  • Intense competition from other major healthcare IT providers, necessitating continuous innovation and differentiation.
  • High implementation costs and lengthy deployment cycles for large-scale EHR systems can be a barrier for some clients.
  • The transition to a subsidiary status may impact independent strategic agility and brand identity.

What Could Drive CERN Stock Higher?

  • **Integration with Oracle Cloud Infrastructure:** Cerner's ongoing integration with Oracle's extensive cloud infrastructure is a significant catalyst, enabling enhanced scalability, security, and performance for its healthcare IT solutions. This integration is expected to unlock new capabilities and efficiencies for Cerner's platforms, making them more attractive to healthcare providers globally.
  • **Launch of New Oracle Health Offerings:** Leveraging Oracle's resources, Cerner is anticipated to contribute to the launch of new, integrated Oracle Health offerings. These could include advanced AI-powered analytics, enhanced interoperability tools, or specialized cloud services tailored for specific healthcare segments, driving increased adoption and market share.
  • **Global Expansion via Oracle's Network:** Cerner's solutions are poised for accelerated global market penetration by leveraging Oracle's vast international sales channels and established presence. This strategic expansion into new geographic regions, particularly in emerging markets, represents a significant growth catalyst for the Cerner business unit within Oracle over the coming years.

What Are the Key Risks for CERN?

  • Rich valuation — a P/E of 52.4 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
  • Insider selling — insiders were net sellers of roughly $7.3M recently.
  • **Intense Competitive Landscape:** The healthcare information technology market remains highly competitive, with numerous established players and agile startups vying for market share. Cerner faces ongoing pressure to innovate and differentiate its offerings to maintain its competitive edge against rivals offering similar EHR, data management, and tech-enabled services.
  • **Regulatory and Compliance Challenges:** The healthcare industry is subject to complex and evolving regulatory frameworks, including data privacy laws (e.g., HIPAA) and interoperability mandates. Cerner must continuously adapt its solutions and operations to ensure compliance, which can incur significant costs and pose risks if not managed effectively.
  • **Cybersecurity Threats and Data Breaches:** As a provider of critical healthcare information technology, Cerner manages vast amounts of sensitive patient data. The potential for cybersecurity threats, data breaches, or system vulnerabilities represents an ongoing and significant risk, which could lead to financial penalties, reputational damage, and loss of customer trust.
  • **Integration Challenges with Oracle:** Despite the strategic benefits, the full integration of Cerner's extensive operations and product lines into Oracle's ecosystem presents potential challenges. These could include cultural clashes, technical complexities, and potential disruptions to existing customer relationships or product development timelines, impacting efficiency and innovation.

What Are the Growth Opportunities for CERN?

  • Growth opportunity 1: **Expansion of Cloud-Based Healthcare Solutions:** The healthcare industry is increasingly migrating to cloud infrastructure for enhanced scalability, security, and accessibility of patient data. Cerner's HealtheIntent platform, a cloud-based solution for data aggregation and reconciliation, is well-positioned to capitalize on this trend. Leveraging Oracle's robust cloud capabilities, Cerner can expand its market share by offering more comprehensive and integrated cloud services, potentially reaching new segments of healthcare providers seeking secure, scalable, and cost-effective IT infrastructure. This market is projected for significant growth, driven by digital transformation initiatives.
  • Growth opportunity 2: **Enhanced Data Analytics and AI Integration:** The immense volume of healthcare data presents a significant opportunity for advanced analytics and artificial intelligence to improve diagnostics, treatment plans, and operational efficiency. Cerner's expertise in healthcare data analysis and real-world evidence generation, combined with Oracle's AI and machine learning capabilities, can lead to the development of new, high-value solutions. These solutions could offer deeper insights into population health, predictive analytics for disease management, and personalized medicine, catering to the growing demand for data-driven healthcare decisions.
  • Growth opportunity 3: **Global Market Penetration:** While Cerner has an international presence, its integration into Oracle Corporation provides a substantial opportunity for accelerated global expansion. Oracle's extensive global sales network, established international data centers, and localized support infrastructure can significantly enhance Cerner's reach into underserved or emerging healthcare markets worldwide. This allows Cerner to introduce its proven EHR and healthcare IT solutions to a broader international client base, adapting to regional regulatory requirements and healthcare delivery models, thereby increasing its total addressable market.
  • Growth opportunity 4: **Interoperability and Device Connectivity:** A persistent challenge in healthcare is the lack of seamless interoperability between disparate systems and medical devices. Cerner's CareAware platform, designed for EHR-agnostic device connectivity, directly addresses this need. There is an ongoing market demand for solutions that facilitate better data exchange between various healthcare technologies. By further developing and integrating CareAware with a wider range of devices and systems, Cerner can strengthen its position as a critical enabler of connected care, enhancing data flow and improving clinical workflows across diverse healthcare environments.
  • Growth opportunity 5: **Revenue Cycle Management and Administrative Optimization:** Healthcare organizations continually seek ways to optimize their financial and administrative processes to reduce costs and improve revenue capture. Cerner's tech-enabled services, including revenue cycle management and clinical process optimization, offer direct solutions to these challenges. By enhancing these service offerings and integrating them more deeply with Oracle's enterprise resource planning (ERP) solutions, Cerner can provide a more holistic administrative and financial management suite. This addresses a persistent pain point for healthcare providers, offering substantial value through improved operational efficiency and financial performance.

What Opportunities Does CERN Have?

  • Growing global demand for digital health solutions, cloud-based EHRs, and advanced healthcare data analytics.
  • Leveraging Oracle's cloud infrastructure and AI capabilities to develop next-generation healthcare IT solutions and expand market reach.
  • Expansion into new geographic markets, particularly in developing regions with increasing healthcare digitalization efforts.
  • Further development of interoperability solutions to connect disparate healthcare systems and devices, addressing a critical industry need.
  • Increased focus on population health management and value-based care models, driving demand for Cerner's data aggregation and analytics platforms.

What Threats Does CERN Face?

  • Rapid technological advancements and disruptive innovations from new entrants or agile competitors.
  • Evolving and complex healthcare regulatory landscape, including data privacy (e.g., HIPAA) and cybersecurity compliance.
  • Significant cybersecurity risks associated with managing vast amounts of sensitive patient health information.
  • Economic downturns or budget constraints within healthcare organizations impacting IT spending.
  • Potential for vendor lock-in concerns among clients, leading them to explore more open or modular solutions.

What Are CERN's Competitive Advantages?

  • **Established Ecosystem:** Cerner Millennium's deep integration across clinical, financial, and management systems creates a sticky ecosystem, making it challenging for clients to switch providers.
  • **Comprehensive Solution Suite:** Offers a broad portfolio from EHRs to cloud platforms and tech-enabled services, providing a one-stop shop for diverse healthcare IT needs.
  • **Data Interoperability Expertise:** Platforms like HealtheIntent and CareAware address critical industry challenges in data aggregation and device connectivity, enhancing value for clients.
  • **Large Installed Base:** A significant number of hospitals and healthcare organizations rely on Cerner, creating network effects and a strong foundation for future growth and service expansion.
  • **Integration with Oracle:** Leveraging Oracle's vast resources, cloud infrastructure, and global presence provides enhanced R&D capabilities, market reach, and competitive scale.

What Does CERN Do?

Cerner Corporation, founded in 1979 and headquartered in North Kansas City, Missouri, has evolved into a prominent global provider of healthcare information technology solutions and tech-enabled services. The company's foundational offering is the Cerner Millennium architecture, a sophisticated person-centric computing framework. This system integrates clinical, financial, and management information, enabling healthcare providers to access an individual's complete electronic health record (EHR) directly at the point of care. It meticulously organizes and delivers critical information to a broad spectrum of professionals, including physicians, nurses, laboratory technicians, pharmacists, and administrative staff, as well as consumers. Beyond its core EHR platform, Cerner developed the HealtheIntent platform, a robust cloud-based solution designed to aggregate, transform, and reconcile data across the entire continuum of care, facilitating comprehensive health management. Additionally, the CareAware platform stands out as an EHR-agnostic solution, ensuring seamless connectivity of various healthcare devices to EHRs, thereby enhancing data flow and operational efficiency. Cerner's extensive portfolio also encompasses a wide array of clinical and financial healthcare information technology solutions, alongside specialized departmental and care coordination tools. The company provides crucial tech-enabled services such as implementation and training, remote hosting, application management, revenue cycle management, support and maintenance, and advanced healthcare data analysis. Its services further extend to real-world evidence generation, clinical process optimization, transaction processing, management of employer health centers, and various data-driven services. Cerner also supplies complementary hardware and devices from third parties. Its diverse client base includes integrated delivery networks, physician groups, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. As of June 8, 2022, Cerner Corporation operates as a subsidiary of Oracle Corporation, marking a significant transition in its corporate structure and strategic direction.

What Products and Services Does CERN Offer?

  • Provides health care information technology solutions and tech-enabled services.
  • Offers Cerner Millennium architecture, a person-centric computing framework for electronic health records (EHRs).
  • Develops HealtheIntent platform, a cloud-based solution for aggregating and reconciling health data.
  • Creates CareAware, an EHR-agnostic platform for connecting healthcare devices to EHRs.
  • Delivers a portfolio of clinical and financial healthcare information technology solutions.
  • Provides tech-enabled services including implementation, training, remote hosting, and application management.
  • Offers revenue cycle management, support, maintenance, and healthcare data analysis services.
  • Supplies complementary hardware and devices from third parties to healthcare clients.

How Does CERN Make Money?

  • Generates revenue through licensing and subscriptions for its software platforms like Cerner Millennium and HealtheIntent.
  • Earns income from a comprehensive suite of tech-enabled services, including implementation, training, remote hosting, and application management.
  • Provides revenue cycle management and clinical process optimization services, helping clients improve financial and operational performance.
  • Offers data-driven services such as healthcare data analysis and real-world evidence generation.
  • Sells complementary hardware and devices from third parties, integrated with its software solutions.

What Industry Does CERN Operate In?

The healthcare information services industry is undergoing rapid transformation, driven by increasing demands for digital health records, data interoperability, and advanced analytics to improve patient outcomes and operational efficiencies. Market trends include the widespread adoption of Electronic Health Records (EHRs), the shift towards cloud-based solutions, and the growing emphasis on population health management and real-world evidence. Cerner Corporation has historically positioned itself as a leader in this landscape, offering comprehensive EHR systems like Cerner Millennium and data platforms such as HealtheIntent. The competitive landscape is intense, featuring major players offering similar integrated solutions. Cerner's strength lies in its established presence, extensive product portfolio, and deep integration capabilities across various healthcare settings. The company's offerings directly address the industry's need for seamless information flow and data-driven decision-making, catering to a broad spectrum of healthcare providers from large integrated delivery networks to individual physician groups.

Who Are CERN's Key Customers?

  • Integrated delivery networks (IDNs) and large hospital systems.
  • Physician groups and networks, including clinics and medical centers.
  • Managed care organizations and health insurance providers.
  • Government health agencies and public health organizations.
  • Free-standing reference laboratories, home health agencies, blood banks, imaging centers, and pharmacies.
AI Confidence: 74% Updated: Jun 14, 2026

Company Profile

Cerner Corporation operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Kansas City, US. The company is led by CEO Brent Shafer. CERN has traded publicly since 1986.

Net sellingInsider Activity

The most recent 12 insider filings for Cerner Corporation break down as 12 sales and 0 purchases. On net that is roughly 200K shares disposed (about $7.3M), a signal worth weighing alongside the fundamentals.

ROE 14%Key Financial Metrics

Return on equity for Cerner Corporation stands at 13.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.5%, showing how much profit it generates from its asset base. CERN trades at a trailing price-to-earnings ratio of 52.39, above the Healthcare sector average of ~23x. A current ratio of 1.51 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.9%, the inverse of the P/E and a quick read on earnings relative to price.

CERN Valuation & Market Position

Relative to its peer group, CERN's quantitative score of 54/100 is below the peer average of 70/100.

CERN Financials

Fundamental Snapshot

P/E (TTM)
52.4
Return on Equity (TTM)
+13.6%
Current Ratio
1.5
EV/EBITDA (TTM)
0.9

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Established market leadership in healthcare information technology with a comprehensive suite of EHR and data management solutions.
  • Robust and integrated platforms like Cerner Millennium and HealtheIntent cater to diverse clinical, financial, and administrative needs.
  • Extensive global client base spanning various healthcare organizations, ensuring broad market penetration and recurring revenue streams.
  • Strong tech-enabled services portfolio, including implementation, revenue cycle management, and data analytics, enhancing customer value.

Bear Case

  • Potential for integration challenges and cultural shifts following the acquisition by Oracle Corporation.
  • Reliance on complex legacy systems could pose modernization challenges and require substantial investment.
  • Intense competition from other major healthcare IT providers, necessitating continuous innovation and differentiation.
  • High implementation costs and lengthy deployment cycles for large-scale EHR systems can be a barrier for some clients.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

CERN Latest News

CERN Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CERN.

Price Targets

Wall Street price target analysis for CERN.

CERN MoonshotScore

54/100

What does this score mean?

The MoonshotScore rates CERN 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Brent Shafer

Former Chief Executive Officer

Brent Shafer served as the Chief Executive Officer of Cerner Corporation, overseeing its global operations and strategic direction prior to its acquisition by Oracle. His leadership was instrumental in guiding the company's focus on healthcare information technology solutions and services. Specific details regarding his full career history, educational background, and previous executive roles beyond his Cerner tenure are not provided in the source data.

Track Record: During his tenure as CEO, Brent Shafer was responsible for managing a substantial workforce of 25,150 employees, a testament to the scale of Cerner's operations. His leadership focused on advancing the company's core mission of providing comprehensive healthcare IT solutions. Specific achievements, strategic decisions, or company milestones directly attributable to his individual leadership beyond the general business operations are not detailed in the provided information.

Common Questions About CERN (Healthcare)

What does the AI Score mean for CERN?

CERN holds an AI Score of 54/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Cerner Corporation, now a subsidiary of Oracle, provides comprehensive healthcare information technology solutions and tech-enabled services globally. Its offerings include electronic health record …

What are Cerner Corporation's primary healthcare technology solutions?

Cerner Corporation provides a comprehensive suite of healthcare information technology solutions designed to streamline operations and enhance patient care. Its flagship offering is the Cerner Millennium architecture, a person-centric computing framework that integrates clinical, financial, and management information into a unified electronic health record (EHR) system. This allows providers to access patient data at the point of care.

How has Cerner Corporation's acquisition by Oracle impacted its market position?

Cerner Corporation's acquisition by Oracle Corporation on June 8, 2022, fundamentally transformed its market position. Prior to the acquisition, Cerner was an independent, publicly traded leader in healthcare IT. As a subsidiary of Oracle, Cerner now operates as a core component of Oracle Health, leveraging Oracle's immense resources, global cloud infrastructure, and enterprise software expertise.

What are the key challenges and opportunities for Cerner Corporation in the evolving healthcare IT landscape?

In the evolving healthcare IT landscape, Cerner Corporation faces both significant challenges and opportunities. A primary challenge is navigating the highly competitive market, which demands continuous innovation to stay ahead of rivals and adapt to new technologies. Regulatory changes, particularly concerning data privacy and interoperability, also present ongoing compliance hurdles.

What are the key factors to evaluate for CERN?

Cerner Corporation (CERN) holds an AI score of 54/100 (moderate). P/E: 52.4x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does CERN data refresh on this page?

CERN's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven CERN's recent stock price performance?

Cerner Corporation (CERN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established market leadership in healthcare information technology with a comprehensive suite of EHR and data management solutions. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CERN overvalued or undervalued right now?

Cerner Corporation (CERN) trades at 52.4x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research CERN before investing?

Before investing in Cerner Corporation (CERN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The financial metrics provided are historical for CERN as a publicly traded company before its acquisition by Oracle on June 8, 2022. The investment thesis and related sections reflect this context.
  • CEO profile details for background and track record are limited to what was explicitly provided in the source data, with 'Unknown' used for specific missing information as per instructions.
  • The company is now a subsidiary of Oracle Corporation, which impacts the interpretation of 'investment thesis' and 'competitors' as it no longer trades independently under CERN.
Data Sources

Popular Stocks